Ioana C. Hone
Contacto de Relaciones con Inversores en LINEAGE CELL THERAPEUTICS, INC. .
Cargos activos de Ioana C. Hone
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | - | - |
Historial de carrera de Ioana C. Hone
Antiguos cargos conocidos de Ioana C. Hone.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LIFEVANTAGE CORPORATION | Public Communications Contact | 21/09/2010 | - |
| SAVARA INC. | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | - | - | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Contacto de Relaciones con Inversores | 12/04/2011 | - |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Sectorial
| Health Technology | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SAVARA INC. | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ioana C. Hone
- Experiencia
